French pharmaceutical company Sanofi will increase its stockpile of drugs in the UK to ensure it has a 14-week supply, in case of disruption caused by a hard Brexit . Hugo Fry , managing director, Sanofi UK , said the move was taken following recommendations from the European Federation of Pharmaceutical Industries and Health , and Sanofi 's own assessments, and had informed Health Secretary Matt Hancock . "Novartis has been in close consultation with the UK government about Brexit-related issues since before the 2016 referendum, both directly and via industry associations. Matt Hancock said he was confident UK patients' medicine supply would not be disrupted. In Sanofi , AstraZeneca said it was increasing stocks by about 20% in case of a hard Brexit .
French pharmaceutical company Sanofi will increase its stockpile of drugs in the UK to ensure it has a 14-week supply, in case of disruption caused by a hard Brexit . Hugo Fry , managing director, Sanofi UK , said the move was taken following recommendations from the European Federation of Pharmaceutical Industries and Health , and Sanofi 's own assessments, and had informed Health Secretary Matt Hancock . Matt Hancock said he was confident UK patients' medicine supply would not be disrupted. In Sanofi , AstraZeneca said it was increasing stocks by about 20% in case of a hard Brexit .